Ischemic Postconditioning in STEMI Patients Treated With Primary PCI

Recruiting N/A Interventional Study
ST Segment Elevation Myocardial Infarction
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
1,800 (estimated)
Sponsor
Rigshospitalet, Denmark · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥18 years * Acute onset of chest pain with \< 12 hours duration * STEMI as characterized by 2 mm ST elevation in 2 or more V1 through V4 leads or presumed new left bundle branch block with minimum of 1 mm concordant ST elevation or 1 mV ST-segment elevation in the limb lea…
Contacts

Thomas Engstrøm, DMSci

+4535458444

thomas.engstroem@regionh.dk

CONTACT

Jacob Lønborg, DMSci

+4535458176

jacob.thomsen.loenborg01@regionh.dk

CONTACT